Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Sell
45
LXEO Quote, Financials, Valuation and Earnings
Last price:
$10.25
Seasonality move
:
-35.91%
Day range:
$10.02 - $10.70
52-week range:
$1.45 - $10.99
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
2.82x
Volume:
522.7K
Avg. volume:
1.3M
1-year change:
51.18%
Market cap:
$340.2M
Revenue:
--
EPS (TTM):
-$2.70
Earnings Data
Next earnings date for LXEO
Mar 23
2026
Most recent earnings per share
-$0.33
Beat by $0.13
(Nov 5/2025)
Consensus Estimate
-$0.46
(Nov 5/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
LXEO Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 03/23/2026 | Q4 | -- | -- | -- | -$0.30 | -- |
| 11/05/2025 | Q3 | -- | -- | -$0.33 | -$0.46 | $0.13 |
| 08/14/2025 | Q2 | -- | -- | -$0.60 | -$0.66 | $0.06 |
| 05/08/2025 | Q1 | -- | -- | -$0.99 | -$0.77 | -$0.21 |
| 03/24/2025 | Q4 | -- | -- | -$0.78 | -$0.78 | -$0.01 |
| 11/13/2024 | Q3 | -- | -- | -$0.89 | -$0.67 | -$0.22 |
| 08/12/2024 | Q2 | -- | -- | -$0.64 | -$0.69 | $0.05 |
| 05/09/2024 | Q1 | -- | -- | -$0.77 | -$0.79 | $0.02 |
| 03/11/2024 | Q4 | -- | -- | -$0.53 | -$0.75 | $0.22 |
| 12/11/2023 | Q3 | -- | -- | -$0.75 | -- | -- |
| 06/30/2023 | Q2 | -- | -- | -$0.50 | -- | -- |
| 03/31/2023 | Q1 | -- | -- | -$0.70 | -- | -- |
| 12/31/2022 | Q4 | -- | -- | -$0.58 | -- | -- |
| 09/30/2022 | Q3 | -- | -- | -$0.68 | -- | -- |
| 06/30/2022 | Q2 | -- | $37K | -$0.57 | -- | -- |
| 03/31/2022 | Q1 | -- | $85.6K | -$0.47 | -- | -- |
Lexeo Therapeutics, Inc. Earnings Questions
-
How Much did Lexeo Therapeutics, Inc. Generate in Revenue Last Quarter?
Lexeo Therapeutics, Inc. reported -- worth of top line sales in its most recent quarter.
-
Did Lexeo Therapeutics, Inc. Beat Earnings Last Quarter?
Lexeo Therapeutics, Inc. announced earnings per share of -$0.33 which represents a beat of analyst forecast a -$0.46 per share.
-
Is Lexeo Therapeutics, Inc. Profitable?
Lexeo Therapeutics, Inc. reported -$530K that represents -$0.01 per share over the last quarter.
-
What is the Analyst Consensus for Lexeo Therapeutics, Inc. EPS Next Year?
Lexeo Therapeutics, Inc.'s earnings are forecast to decrease from -$3.09 per share to -$3.09 per share next year representing a decrease of -37.85%.
-
When is Lexeo Therapeutics, Inc.'s Earnings Date?
Lexeo Therapeutics, Inc.'s next earnings date is March 23, 2026.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Is Broadcom Stock on Sale?
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Stock Ideas
Buy
59
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 65x
Buy
55
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
72
GLTO alert for Dec 29
Galecto, Inc. [GLTO] is down 12.13% over the past day.
Sell
20
SMX alert for Dec 29
SMX (Security Matters) Plc [SMX] is down 27.67% over the past day.
Sell
11
CDNAF alert for Dec 29
Canadian Tire Corp. Ltd. [CDNAF] is up 11.94% over the past day.
